Clinical trial
Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers - a Randomized, Controlled, Two-armed Intervention Study
NCT03162289 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers - a Randomized, Controlled, Two-armed Intervention Study
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 10, 2017
- Completion date
- June 10, 2025
- Enrollment
- 150 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, ovarian cancer